Adaptability serves as the foundation for lasting career success, shaping leaders who can thrive in an ever-changing business ...
Criminal enforcement of the Foreign Corrupt Practices Act was paused on February 10 by a Trump administration executive order ...
Then: In the May 2023 issue of Life Science Leader, Bobak Azamian, MD, Ph.D., cofounder and CEO of Tarsus Pharmaceuticals, talked about the company’s formation in 2016, and the decision to focus on ...
This article is the second installment of a three-part series aimed at helping drug and device manufacturers better navigate and understand the VA and DOD health systems. The first installment in the ...
The Companies to Watch column spotlights small, entrepreneurial biopharma companies that are developing their own products (not just a platform) with little or no press coverage to date, and offering ...
Considering how hard it is for people, let alone companies, to say “Hmmm. We may have made a mistake. Let’s try something else,” it’s refreshing to hear how a company not only did that, but is ...
Managing third-party risk is one of the most arduous challenges facing pharmaceutical companies, and regulatory requirements are just one piece of this puzzle. Pharmaceutical organizations are ...
A substantial share of biopharmaceutical drug launches (>50%) fail to meet their projected analyst forecasts (see also Simon-Kucher Biotech industry study 2019). With considerable investment going ...
Life Science Leader is an essential business publication for life science executives who work at everything from emerging biotechs to large pharmaceutical companies. Our content is designed to inform ...
NCBiotech and their coalition of partners received a $25 million Phase 2 award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. This award will further ...
How is the state of the industry being affected by government policies, talent pools, and supply chain constraints? Hear from Dave Tudor, Managing Director of Pharma, HealthTech, and Quality at CPI, a ...